238 related articles for article (PubMed ID: 16266359)
81. Intravenous lidocaine in the treatment of refractory headache: a retrospective case series.
Rosen N; Marmura M; Abbas M; Silberstein S
Headache; 2009 Feb; 49(2):286-91. PubMed ID: 19222600
[TBL] [Abstract][Full Text] [Related]
82. Pain in patients with chronic idiopathic axonal polyneuropathy.
Erdmann PG; van Genderen FR; Teunissen LL; Notermans NC; Lindeman E; van Wijck AJ; van Meeteren NL
Eur Neurol; 2010; 64(1):58-64. PubMed ID: 20634621
[TBL] [Abstract][Full Text] [Related]
83. Expanding the use of topical anesthesia in wound management: sequential layered application of topical lidocaine with epinephrine.
Gaufberg SV; Walta MJ; Workman TP
Am J Emerg Med; 2007 May; 25(4):379-84. PubMed ID: 17499653
[TBL] [Abstract][Full Text] [Related]
84. [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
Provinciali L; Lattanzi S; Chiarlone R; Fogliardi A; Intelligente F; Irace C; Lanzilotta M; Palomba R; Storelli E; Zampi M
Minerva Med; 2014 Dec; 105(6):515-27. PubMed ID: 25392960
[TBL] [Abstract][Full Text] [Related]
85. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.
Kadiroglu AK; Sit D; Kayabasi H; Tuzcu AK; Tasdemir N; Yilmaz ME
J Diabetes Complications; 2008; 22(4):241-5. PubMed ID: 18413214
[TBL] [Abstract][Full Text] [Related]
86. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).
Cheville AL; Sloan JA; Northfelt DW; Jillella AP; Wong GY; Bearden Iii JD; Liu H; Schaefer PL; Marchello BT; Christensen BJ; Loprinzi CL
Support Care Cancer; 2009 Apr; 17(4):451-60. PubMed ID: 19142669
[TBL] [Abstract][Full Text] [Related]
87. [Intraosseous blocks in the treatment of symmetrical distal diabetic polyneuropathy].
Sokov EL; Kornilova LE; Artiukov OP
Ter Arkh; 2013; 85(4):61-5. PubMed ID: 23808295
[TBL] [Abstract][Full Text] [Related]
88. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.
Jensen MP; Dworkin RH; Gammaitoni AR; Olaleye DO; Oleka N; Galer BS
J Pain; 2005 Feb; 6(2):98-106. PubMed ID: 15694876
[TBL] [Abstract][Full Text] [Related]
89. Capsaicin. Neuropathic pain: playing with fire...
Prescrire Int; 2010 Aug; 19(108):153-5. PubMed ID: 20939441
[TBL] [Abstract][Full Text] [Related]
90. Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.
Gálvez R; Navez ML; Moyle G; Maihöfner C; Stoker M; Ernault E; Nurmikko TJ; Attal N
Clin J Pain; 2017 Oct; 33(10):921-931. PubMed ID: 28872473
[TBL] [Abstract][Full Text] [Related]
91. New analgesics for neuropathic pain: the lidocaine patch.
Argoff CE
Clin J Pain; 2000 Jun; 16(2 Suppl):S62-6. PubMed ID: 10870742
[TBL] [Abstract][Full Text] [Related]
92. Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report.
Hans GH; Robert DN; Van Maldeghem KN
Spinal Cord; 2008 Apr; 46(4):311-3. PubMed ID: 17607309
[TBL] [Abstract][Full Text] [Related]
93. Differential effects of a 5% lidocaine medicated patch in peripheral nerve injury.
Madsen CS; Johnsen B; Fuglsang-Frederiksen A; Jensen TS; Finnerup NB
Muscle Nerve; 2013 Aug; 48(2):265-71. PubMed ID: 23653369
[TBL] [Abstract][Full Text] [Related]
94. Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain.
Webster LR; Peppin JF; Murphy FT; Tobias JK; Vanhove GF
J Pain Res; 2012; 5():7-13. PubMed ID: 22328830
[TBL] [Abstract][Full Text] [Related]
95. Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy.
Haroutounian S; Nikolajsen L; Bendtsen TF; Finnerup NB; Kristensen AD; Hasselstrøm JB; Jensen TS
Pain; 2014 Jul; 155(7):1272-1279. PubMed ID: 24704366
[TBL] [Abstract][Full Text] [Related]
96. Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol.
Kopsky DJ; van Eijk RPA; Warendorf JK; Keppel Hesselink JM; Notermans NC; Vrancken AFJE
Trials; 2022 Oct; 23(1):888. PubMed ID: 36273216
[TBL] [Abstract][Full Text] [Related]
97. Efficacy and safety of intravenous immunoglobulin as adjuvant treatment for refractory neuropathic pain. Results of an open-label, multicenter study.
Jann S; Francia A; Fruguglietti ME; De Toni Franceschini L; Sterzi R
Pain Med; 2012 Oct; 13(10):1334-41. PubMed ID: 22958476
[TBL] [Abstract][Full Text] [Related]
98. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.
Clifford DB; Simpson DM; Brown S; Moyle G; Brew BJ; Conway B; Tobias JK; Vanhove GF;
J Acquir Immune Defic Syndr; 2012 Feb; 59(2):126-33. PubMed ID: 22067661
[TBL] [Abstract][Full Text] [Related]
99. The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients.
Hussain N; Said ASA; Javaid FA; Al Haddad AHI; Anwar M; Khan Z; Abu-Mellal A
J Diabetes Metab Disord; 2021 Jun; 20(1):271-278. PubMed ID: 34178837
[TBL] [Abstract][Full Text] [Related]
100. Utility of lidocaine as a topical analgesic and improvements in patch delivery systems.
Gudin J; Nalamachu S
Postgrad Med; 2020 Jan; 132(1):28-36. PubMed ID: 31900074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
